Secondary analysis of a trial in 49 adolescents with MDD given three esketamine or midazolam infusions: 10 inflammatory markers changed over time in both groups, with no significant drug effect; exploratory links of IL-8, IFN-γ and C4 with response.
Secondary analysisn = 49
Lan et al. Multiple peripheral inflammatory markers in adolescents with major depressive disorder treated with repeated esketamine infusions: results from a randomized controlled trial